(1888PressRelease)
July 12, 2009 - Hyderabad, India: The results will be available on the Company’s website www.drreddys.com
Summary of Events
Event Date and Time (IST) Medium
Release of financial results - July 21, after the Board Meeting
Earnings Call - July 21, 6.30 PM IST / 9.00 AM EST
Hosted by the Company(Details below)
Webcast of Earnings Call - July 21, 6.30 PM IST / 9.00 AM EST through July 28, 2009
Transcripts of the Earnings call
Earnings Call:
Following the release, the management of the Company will host an earnings call to discuss the Company’s financial performance.
Conference Dial-In Numbers
Primary Number:
Secondary Number:
+91 22 6629 0101
+91 22 3065 1010
The numbers listed above are universally accessible from all networks and all countries.
Local Access Number: * 60001221
Available in - Delhi, Chennai, Hyderabad, Bangalore, Kolkata
* The Local Access Number is accessible from all major carriers except BSNL/MTNL
International Toll Free Number: USA: 1 866 746 2133
UK: 0 808 101 1573
Singapore: 800 101 2045
Hong Kong: 800 964 448
No password/pin number is necessary to dial in to any of the other calls. As participation in the call is limited, early registration is encouraged. The operator will provide instructions on asking questions before and during the call.
Audio Webcast
The audio webcast of the earnings call will be available to all interested parties at www.drreddys.com. Please visit the web site at least fifteen minutes ahead of the scheduled start time to register and to download and install any necessary audio software. Participants in the webcast can listen to the proceedings, but will not be able to ask questions. The replay will be available 2 hours after the earnings call, through July 28, 2009. For play back dial in phone No: 022 3065 1212 and ID: 375#.
Transcript
The transcript of the earnings call will also be available on the Company's website.
About Dr Reddy’s
Established in 1984, Dr. Reddy’s Laboratories (NYSE: RDY) is an emerging global pharmaceutical company with proven basic research capabilities. The company develops, manufactures and markets a wide range of pharmaceutical products in India and overseas. Dr. Reddy’s produces finished dosage forms, active pharmaceutical ingredients, diagnostic kits, critical care and biotechnology products. The basic research program of Dr. Reddy’s focuses on cancer, diabetes, bacterial infections and pain management. Website: www.drreddys.com
Contact
For further information please contact:
Investor Relations:
Kedar Upadhye at kedaru ( @ ) drreddys dot com /+91-40-66834297 | Raghavender R at raghavenderr ( @ ) drreddys dot com /+91-40-66511529 | Milan Kalawadia (North America) at mkalawadia ( @ ) drreddys dot com or at 908-203-4931
###
